Our CEO, John Zutter, joined other industry leaders on stage at HLTH 2024 to discuss the challenges employers face when considering digital health solutions to offer employees. The conversation opened with a daunting question: Is selling to employers still viable?
We believe the answer is yes. The landscape that specialty care faces in selling to employers might be shifting in a more challenging direction as employers become more prescriptive in the benefits programs they offer, but these are the moments that spur the most innovation and creativity to tackle these issues head-on. At Lantern, we’re committed to supporting self-insured employers in reducing healthcare costs while providing specialty care that is both high-quality and highly accessible.
While at HLTH, John also spoke with Arundhati Parmar at MedCity News about how Lantern delivers cost savings to employers.
Lantern targets the most expensive areas of healthcare for employers—including cancer care, surgery care, and infusion care, which account for almost 50% of overall spending—where we can most effectively and significantly alleviate these pain points. Solutions that make patients want to engage with their health without adding any sense of unnecessary stress or burden are the ones that have lasting power and increase utilization rates. This is why we also focus heavily on local access and reducing travel burdens.
“We want to have a network that consists of teaching institutes, for the rare and the complex; hospitals, for when that’s appropriate; and out-patient settings, for when that’s optimized,” Zutter told Arundhati.
The theme of HLTH 24 was to “Be Bold,” and our vision to make specialty care more accessible for all workforces certainly matches the description. But this is more than an ambition—it’s something we’re realizing each and every day with a service experience that makes a difference for employers and employees alike.
